Skip to content

Net Income at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$34.1M-34,000%
Azenta logo
AzentaAZTA
-$160.8M-237%
Quest Diagnostics logo
Quest DiagnosticsDGX
$252M+14.5%
NeoGenomics logo
NeoGenomicsNEO
-$17.11M+34.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$14.84M-158%
Exagen Inc. logo
Exagen Inc.XGN
-$3.97M-5.7%

Other financials

Income statement

See full
Revenue$3.5B+5.8%
Gross profit$1.0B+6.9%
Operating income$380.8M+16.8%
EPS (diluted)$3.35+32.9%

Balance sheet

See full
Cash & equivalents$981.1M+166%
Total debt$7.2B+11.1%
Total equity$8.7B+5.1%
Total assets$19.1B+8.4%

Cash flow

See full
Operating cash flow$191.5M+935%
CapEx$121.0M-4.0%
Free cash flow$70.5M+166%

Valuation

See full
Market cap$22.96B+9.4%
Enterprise value$29.22B+10.7%
P/E24.4×-3.1×
P/S1.6×+0.1×

Profitability

See full
Gross margin28.8%+0.9pp
Operating margin10.2%+1.9pp
Net margin6.7%+1.1pp
FCF margin9.8%+1.0pp

Returns & leverage

See full
Return on equity11.1%+2.1pp
Debt / equity0.8×0.0×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Labcorp Holdings's net income?
Labcorp Holdings (LH) reported net income of $277.8M in Q1 2026.
How has Labcorp Holdings's net income changed year-over-year?
Labcorp Holdings's net income increased by 30.5% year-over-year, from $212.8M to $277.8M.
What is the long-term trend for Labcorp Holdings's net income?
Over 3 years (2021 to 2025), Labcorp Holdings's net income has grown at a -28.3% compound annual growth rate (CAGR), from $2.38B to $876.5M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.